PRESS RELEASE published on 02/05/2026 at 00:00, 7 months 18 days ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus Onco-Innovations Limited announces filing of preliminary base shelf prospectus with securities regulatory authorities in several provinces for potential future offerings. Company focuses on cancer research and treatment Forward-looking Statements Cancer Research Securities Offering Base Shelf Prospectus Onco-Innovations Limited
BRIEF published on 01/24/2026 at 01:05, 7 months 30 days ago Onco-Innovations annonce un placement privé de 2 millions de dollars Placement Privé Approbations Réglementaires Actions Et Bons De Souscription Levée De Capitaux Onco-Innovations
BRIEF published on 01/24/2026 at 01:05, 7 months 30 days ago Onco-Innovations Announces $2 Million Private Placement Private Placement Regulatory Approvals Capital Raising Shares And Warrants Onco-Innovations
PRESS RELEASE published on 01/24/2026 at 01:00, 7 months 30 days ago Onco-Innovations Announces Private Placement Onco-Innovations Limited announces private placement of Units and Admin Fee Shares for potential gross proceeds of $2,000,000 to fund cancer research and treatment endeavors Private Placement Units Cancer Research Admin Fee Shares Onco-Innovations Limited
BRIEF published on 01/22/2026 at 00:05, 8 months 1 day ago Onco-Innovations Partners with i2i Marketing for Market Awareness Cancer Research Corporate Communications Market Awareness I2i Marketing Group Onco-Innovations
BRIEF published on 01/22/2026 at 00:05, 8 months 1 day ago Onco-Innovations s'associe à i2i Marketing pour accroître sa notoriété sur le marché. Connaissance Du Marché Communications D'entreprise Recherche Sur Le Cancer Onco-Innovations Groupe De Marketing I2i
PRESS RELEASE published on 01/22/2026 at 00:00, 8 months 1 day ago Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services Onco-Innovations Limited partners with i2i Marketing Group, LLC for market awareness services and recovers €213,000 from prior engagement. Company aims to enhance visibility and shareholder base Cancer Research Corporate Communications Market Awareness I2i Marketing Group Onco-Innovations Limited
BRIEF published on 12/10/2025 at 00:05, 9 months 13 days ago Onco-Innovations Leads Precision Oncology Forum for Future Cancer Care Cancer Care Precision Oncology Global Health Onco-Innovations Data Innovation
BRIEF published on 12/10/2025 at 00:05, 9 months 13 days ago Onco-Innovations anime le Forum d'oncologie de précision pour les soins futurs contre le cancer Soins Contre Le Cancer Oncologie De Précision Santé Mondiale Onco-Innovations Innovation Des Données
PRESS RELEASE published on 12/10/2025 at 00:00, 9 months 13 days ago Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care Onco-Innovations completes fourth session of Colorectal Cancer Canada's Catalysts Series focused on precision oncology and data-driven innovation, with key industry leaders participating in discussions on advancing national progress Precision Oncology Onco-Innovations Colorectal Cancer Canada Data-driven Innovation National Progress
Published on 09/23/2026 at 08:00, 1 hour 3 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 09/23/2026 at 07:30, 1 hour 33 minutes ago Tocvan Expands El Mezquite; Drilling Returns 106.8 m of 0.5 g/t Au
Published on 09/23/2026 at 04:45, 4 hours 18 minutes ago SAINT BELLA Marks First Anniversary at Waldorf Astoria Monarch Beach
Published on 09/23/2026 at 02:45, 6 hours 18 minutes ago Presentation to Beaver Creek Precious Metals Summit
Published on 09/23/2026 at 02:00, 7 hours 3 minutes ago Battery X Metals Announces up to $1 Million Private Placement Financing to Advance Corporate Growth Initiatives
Published on 09/23/2026 at 08:30, 33 minutes ago SBF AG reports a significant improvement in earnings in the first half of 2026
Published on 09/23/2026 at 08:20, 42 minutes ago ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline
Published on 09/23/2026 at 08:19, 44 minutes ago HPW strengthens Garsten site with new copper wire casting plant and focuses on sustainable production
Published on 09/23/2026 at 08:00, 1 hour 3 minutes ago Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€
Published on 09/22/2026 at 18:00, 15 hours 3 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 15 hours 3 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 15 hours 18 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026